Send Away Test for Oncotype DX Breast Recurrence Score

A Contract Award Notice
by GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST

Source
Find a Tender
Type
Contract (Services)
Duration
not specified
Value
£215K
Sector
HEALTH
Published
03 Feb 2026
Delivery
not specified
Deadline
n/a

Related Terms

Location

Gloucester

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.

Total Quantity or Scope

This contract is to commission Exact Science to provide Oncotype DX Breast Recurrence Score which is a genomic assay that provides a personalised insight into an individual patients breast cancer biology. This contract has been awarded under Direct Award A The lifetime value of this contract is £214,650 The contract is in place from 1st July 2025 until 30th June 2026

Award Detail

1 Exact Sciences (London)
  • Num offers: 1
  • Value: £214,650
  • Contractor is an SME.

Award Criteria

PRICE _

CPV Codes

  • 85111800 - Pathology services

Indicators

  • Award on basis of price.

Other Information

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provision of the Public Contracts Regulations 2015 do not apply to this award. Decision Makers involved were Siobhan Taylor, Lead Clinical Scientist, Kelly Attwood, Contracts Manager There were no conflicts of interests declared.

Reference

  • FTS 009502-2026

Domains